Lung AI vs Revolution Vibe
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools offer adjacent comparability, both leveraging AI for cardiac and imaging applications, but with distinct approaches. Lung AI provides a handheld, on-device ultrasound solution for real-time decisions and lung/cardiac scanning, while Revolution Vibe is an on-premise CT system optimized for advanced cardiac imaging with comprehensive workflow automation. The choice depends on the specific need for portability and real-time point-of-care versus high-fidelity, detailed cardiac CT imaging.
Choose Lung AI if…
Choose Lung AI if you need a portable, real-time diagnostic tool for rapid assessment of cardiac and lung conditions at the point of care. Its on-device AI can quickly detect pleural effusion, consolidation/atelectasis, and assess cardiac function (like LVEF) in various settings, including emergency medicine and critical care, even with less-than-perfect scans.
View Lung AI →Choose Revolution Vibe if…
Choose Revolution Vibe if your primary need is high-quality, low-dose cardiac CT imaging for complex cases, particularly Coronary CT Angiography (CCTA). This on-premise CT system excels in scenarios involving arrhythmias, heavily calcified coronaries, or when simplified patient preparation (e.g., ECG-less cardiac CT) and streamlined workflows are crucial for diagnostic accuracy and efficiency.
View Revolution Vibe →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Lung AI | Revolution Vibe |
|---|---|---|
| Pricing | Contact for pricing | Contact vendor for quote |
| Deployment | On-device (integrated with Exo Iris handheld ultrasound device) | On-premise (physical medical device installation) |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Lung AI | Revolution Vibe |
|---|---|---|
| Tool Name | Lung AI | Revolution Vibe |
| Company | Exo | GE HealthCare |
| Tagline | Handheld AI Ultrasound for Smarter Cardiac and Lung Scanning. | A new vision for every heart. Effortless Cardiac workflow for every user. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Emergency Medicine, Pulmonology | Cardiology, Cardiothoracic Surgery, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Lung AI and Revolution Vibe.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
While the provided information doesn't detail specific EHR integration methods, both tools aim to streamline workflows. Revolution Vibe's AI-powered Effortless Cardiac Workflow is designed to automate protocol selection and patient positioning, reducing scan time and simplifying operation, which would inherently improve workflow efficiency. Exo Lung AI, being an on-device AI for a handheld ultrasound, processes AI on the device without internet, suggesting a more immediate, point-of-care workflow, but specific EHR integration would likely depend on the handheld device's connectivity capabilities.
Exo Lung AI shows high accuracy for pleural effusion detection with a sensitivity of 0.967 and specificity of 0.912, and for consolidation/atelectasis detection with a sensitivity of 0.968 and specificity of 0.945. It also demonstrates high diagnostic accuracy for A-lines (sensitivity 91%, specificity 81%) and B-lines (sensitivity 84%, specificity 86%). Revolution Vibe is designed to deliver consistently exceptional image quality for accurate diagnoses, even in challenging patients, with a reported increase in CCTA success rate from 77% to 96% in a comparative study.
Exo Lung AI is designed to be user-friendly, with studies showing that AI assistance significantly improves sensitivity, particularly for less experienced users, with performance approaching expert levels. Revolution Vibe's AI-powered Effortless Cardiac Workflow is intended to simplify scanning and reduce dependency on user experience, suggesting a reduced learning curve for technologists.
GE HealthCare's Revolution Vibe includes staff training and a Smart Subscription to keep equipment current, along with predictive maintenance and fleet management tools. Exo offers Exo U for AI-powered POCUS education and training, indicating a focus on user proficiency and ongoing learning.
Exo Lung AI operates with on-device AI processing, meaning it functions without an internet connection, which inherently limits external data transmission risks. The provided information for Revolution Vibe does not detail security features beyond HIPAA compliance, but as an on-premise physical medical device, its security posture would typically involve network security and access controls within the hospital's infrastructure.
The provided information does not explicitly detail audit-trail features for either Exo Lung AI or Revolution Vibe. However, both are medical devices operating in clinical settings, implying a need for such capabilities to support accountability and quality assurance, which would typically be part of their software design.
Exo Lung AI's on-device AI processing means it operates without internet, potentially simplifying deployment across various sites as it doesn't rely on centralized cloud infrastructure for AI computations. Revolution Vibe's AI-powered workflow aims for consistency across various technologists, which could aid in standardized performance during multi-site rollouts, and GE HealthCare offers extensive training and fleet management tools to support such deployments.